Niacin shrinks artery plaque; Merck's Zetia does not and may carry risks, new study finds

ORLANDO, Fla. - A new study raises fresh concerns about Zetia and its cousin, Vytorin - drugs that are still taken by millions of people to lower cholesterol, despite questions raised last year about how well they work....More